Skip to content

Clinical trials

Phase 2 Sleep Initiation and Maintenance Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sleep Initiation and Maintenance Disorders Phase: Phase 2 Country / region: United States Clear all

82 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20032
20044
20051
20069
20077
20087
20092
20113
20123
20132
20141
20153
20162
20172
20182
20192
20204
20211
20224
20236
20245
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed60
Recruiting11
Terminated4
Active, not recruiting3
Not yet recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Idorsia Pharmaceuticals Ltd.4
Stanford University3
Takeda3
Arena Pharmaceuticals2
Eli Lilly and Company2
Evotec Neurosciences GmbH2
Janssen Research & Development, LLC2
Johns Hopkins University2
National Center for Complementary and Integrative Health (NCCIH)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sleep Initiation and Maintenance Disorders82
Stress Disorders, Post-Traumatic6
Anxiety Disorders5
Alzheimer Disease4
Pain4
Chronic Pain3
Cognitive Dysfunction3
Multiple Sclerosis3
Opioid-Related Disorders3
Sleep Deprivation3

Trials

Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.